Physician profile
Peter Ryg
NPI 1184982977
$3,655.11
in general payments reported to CMS, 2019-2025
19 companies · $581 in 2025
The $581 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $139 · 2021: $77.73 · 2022: $628 · 2023: $1,014 · 2024: $714 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,165 · Entertainment: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,165.11 |
| Entertainment | $144.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $816.80 | 2022-2025 | Lumigan, Alphagan P, Durysta |
| Biotissue Holdings INC. | $807.84 | 2019-2025 | |
| Alcon Vision LLC | $446.91 | 2021-2025 | Clareon, Centurion, Unity |
| Genentech USA, INC. | $268.20 | 2022-2023 | Vabysmo |
| Rxsight INC | $197.03 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| New World Medical,INC. | $149.60 | 2023 | |
| Optos, INC. | $144.43 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Regeneron Pharmaceuticals, INC. | $135.01 | 2022 | |
| Apellis Pharmaceuticals, INC. | $119.32 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $101.01 | 2019 | |
| Allergan, INC. | $100.82 | 2019-2021 | |
| Optovue, INC. | $100.00 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $97.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $50.36 | 2019 | |
| Bausch & Lomb Americas INC. | $31.59 | 2025 | Vyzulta |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $24.43 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $22.64 | 2023 | Iolmaster 700 |
| Harrow Eye, LLC | $21.88 | 2025 | |
| Amgen INC. | $19.27 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ryg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.